Diabetes Clinical Trials in North Carolina

Showing 241-260 of 533 trials

A Study of LY3209590 in Participants With Type 2 Diabetes

NCT03367377

This study will evaluate the safety and tolerability of LY3209590 when given by injection under the skin to participants with type 2 diabetes. It will also investigate how the body processes the study drug and the effect of the study drug on blood sugar levels. Information about any side effects will be documented. This study will last approximately 17 weeks, not including screening. Screening is required within 4 weeks prior to the start of the study.

Diabetes Mellitus, Type 2

Eli Lilly and Company70 participantsStarted Jan 2018

South Miami, Florida, United States • High Point, North Carolina, United States • Toronto, Ontario, Canada

TERMINATEDPhase 325 miles

Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

NCT00411892

This trial is conducted in the United States of America (USA). This trial will compare the changes in HbA1c after 26 weeks of inhaled insulin and pioglitazone combination therapy versus pioglitazone treatment alone.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S196 participantsStarted Nov 2006

Ozark, Alabama, United States • Tuscaloosa, Alabama, United States • Vestavia Hills, Alabama, United States +107 more locations

A Study of LY3209590 in Participants With Type 2 Diabetes

Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

Diabetes Trials in Other Cities

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Lifestyle Intervention for Treatment of Diabetes

CANVAS - CANagliflozin cardioVascular Assessment Study

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Evaluation of the Accuracy of an Implanted Glucose Sensor

A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus

Physical and Cognitive Function - Look AHEAD Ancillary Study

Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial

Other Conditions in North Carolina